EAM
MED icon

Eukles Asset Management’s Medifast MED Stock Holding History

Eukles Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-268
Closed -$4.72K – 227
2024
Q4 		$4.72K Sell
268
-20
-7% -$371 ﹤0.01% 179
2024
Q3 		$5.51K Sell
288
-35
-11% -$674 ﹤0.01% 175
2024
Q2 		$7.05K Sell
323
-39
-11% -$1.04K ﹤0.01% 164
2024
Q1 		$13.9K Sell
362
-782
-68% -$37.9K 0.01% 143
2023
Q4 		$76.9K Sell
1,144
-77
-6% -$5.36K 0.04% 103
2023
Q3 		$91.4K Hold
1,221
– – 0.05% 101
2023
Q2 		$113K Hold
1,221
– – 0.06% 98
2023
Q1 		$127K Buy
1,221
+8
+0.7% +$887 0.07% 97
2022
Q4 		$140K Hold
1,213
– – 0.08% 97
2022
Q3 		$131K Buy
1,213
+79
+7% +$11.3K 0.09% 97
2022
Q2 		$205K Buy
1,134
+1
+0.1% +$179 0.13% 91
2022
Q1 		$193K Sell
1,133
-39
-3% -$7.35K 0.1% 96
2021
Q4 		$245K Sell
1,172
-108
-8% -$22.3K 0.12% 94
2021
Q3 		$247K Buy
1,280
+211
+20% +$51.9K 0.14% 91
2021
Q2 		$303K Buy
+1,069
New +$290K 0.17% 85

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Eukles Asset Management's MED Position: Q1 2025 in Review

Eukles Asset Management sold out of Medifast (MED) in Q1 2025, closing a stake of 268 shares — an estimated $4.72K sold.

Eukles Asset Management first reported a position in MED in Q2 2021 and held it in 15 quarters. The position peaked at $303K in Q2 2021. 124 funds tracked by Wall St. Rank hold MED as of Q1 2025.

  • Eukles Asset Management reported no remaining Medifast position as of Q1 2025 after selling out during the quarter.
  • Eukles Asset Management sold 268 Medifast shares in Q1 2025, an estimated $4.72K.
  • Eukles Asset Management first reported a position in Medifast in Q2 2021 and held it in 15 quarters.
  • Eukles Asset Management's Medifast position peaked at $303K in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q1 2025.

Based on Eukles Asset Management's 13F filing for Q1 2025, filed 29 Apr 2025.